{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:27:11Z","timestamp":1791973631243,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPB"],"published-print":{"date-parts":[[2014,1,31]]},"DOI":"10.2174\/1389201014666131226122243","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T10:38:34Z","timestamp":1391683114000},"page":"878-886","source":"Crossref","is-referenced-by-count":16,"title":["Rational Considerations about Development of Live Attenuated Yersinia pestis Vaccines"],"prefix":"10.2174","volume":"14","author":[{"given":"Wei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Curtiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/119186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T03:42:26Z","timestamp":1448250146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1389-2010&volume=14&issue=10&spage=878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,1,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201014666131226122243","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,31]]}}}